Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.
about
Controlled attenuation parameter for assessment of hepatic steatosis grades: a diagnostic meta-analysisControlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).Non-invasive diagnosis of hepatic steatosis.The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis.The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
P2860
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Controlled attenuation paramet ...... is in chronic viral hepatitis.
@ast
Controlled attenuation paramet ...... is in chronic viral hepatitis.
@en
type
label
Controlled attenuation paramet ...... is in chronic viral hepatitis.
@ast
Controlled attenuation paramet ...... is in chronic viral hepatitis.
@en
prefLabel
Controlled attenuation paramet ...... is in chronic viral hepatitis.
@ast
Controlled attenuation paramet ...... is in chronic viral hepatitis.
@en
P2093
P2860
P50
P356
P1476
Controlled attenuation paramet ...... sis in chronic viral hepatitis
@en
P2093
Barbara Dal Bello
Carlo Filice
Gaetano Filice
Mabel Zicchetti
P2860
P304
P356
10.3748/WJG.V20.I21.6626
P407
P577
2014-06-01T00:00:00Z